Organization Overview
Alternative names
acamprosate (campral) (8 trials)
bupropion (wellbutrin) (8 trials)
cabotegravir (Vocabria) (1 trial)
carbamazepine (tegretol) (1 trial)
dutasteride (avodart) (5 trials)
emtricitabine (emtriva) (1 trial)
fluoxetine (prozac) (4 trials)
hepatitis a vaccine, inactivated (vaqta) (2 trials)
hepatitis b vaccine (recombinant) (Recombivax) (3 trials)
acetylcysteine (mucomyst) (4 trials)
atomoxetine (strattera) (4 trials)
bone marrow derived mesenchymal stem cells (1 trial)
brexpiprazole (rexulti) (1 trial)
choline c11 (choline c-11) (1 trial)
citalopram (celexa) (2 trials)
duloxetine (Cymbalta) (2 trials)
fenofibrate (fenoglide) (1 trial)
Filgrastim (neupogen) (2 trials)
human fecal microbiota (Reybota) (1 trial)
hyperimmune bovine colostrum (1 trial)
icosapent ethyl (vascepa) (2 trials)
interferon alpha-2b (Intron-A) (1 trial)
lactobacillus rhamnosus (2 trials)
memantine (namenda) (3 trials)
mifepristone (mifeprex) (3 trials)
minocycline (minocin) (2 trials)
mirtazapine (remeron) (1 trial)
mycophenolate (CellCept) (1 trial)
obeticholic acid (ocaliva) (2 trials)
omega-3 fatty acids (Omacor) (1 trial)
perampanel (fycompa) (1 trial)
pioglitazone (actos) (4 trials)
polyene phosphatidylcholine (1 trial)
prazosin (minipress) (6 trials)
Acquired Immunodeficiency Syndrome (Phase 3)
Alcohol Drinking (Phase 4)
Alcoholic Intoxication (Phase 4)
Alcohol-Induced Disorders (Phase 4)
Alcoholism (Phase 4)
Alcohol-Related Disorders (Phase 4)
Anxiety Disorders (Phase 4)
Behavior, Addictive (Phase 4)
Binge Drinking (Phase 2)
Bipolar Disorder (Phase 4)
Brain Injuries (Phase 2)
Brain Injuries, Traumatic (Phase 2)
Chemically-Induced Disorders (Phase 1)
Chronic Pain (Phase 4)
Cocaine-Related Disorders (Phase 2)
Cognition Disorders (Phase 1)
Cognitive Dysfunction (Phase 2)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Depressive Disorder, Major (Phase 2)
Disease (Phase 4)
Drinking Behavior (Phase 2)
Dyssomnias (Phase 2)
Emergencies (Phase 4)
Encephalitis (Phase 1)
Fatty Liver (Phase 1)
Fatty Liver, Alcoholic (Phase 1)
Feeding and Eating Disorders (Phase 4)
Fetal Alcohol Spectrum Disorders (Phase 2)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis, Alcoholic (Phase 3)
Hepatitis B (Phase 4)
Hepatitis C (Phase 2)
HIV Infections (Phase 4)
Hypersensitivity (Phase 1)
Infections (Phase 4)
Inflammation (Phase 2)
Insulin Resistance (Phase 2)
Liver Diseases (Phase 3)
Liver Diseases, Alcoholic (Phase 3)
Marijuana Abuse (Phase 2)
Mental Disorders (Phase 4)
Neurobehavioral Manifestations (Phase 2)
Neurocognitive Disorders (Phase 1)
Neurodevelopmental Disorders (Phase 2)
Opioid-Related Disorders (Phase 4)
Pancreatitis (Phase 2)
Pancreatitis, Chronic (Phase 2)
Parasomnias (Phase 2)
Pathologic Processes (Phase 1)
Phobia, Social (Phase 4)
Psychotic Disorders (Phase 4)
Schizophrenia (Phase 4)
Sepsis (Phase 2)
Sleep Wake Disorders (Phase 2)
Stress Disorders, Post-Traumatic (Phase 4)
Stress Disorders, Traumatic (Phase 4)
Substance-Related Disorders (Phase 4)
Substance Withdrawal Syndrome (Phase 4)
Syndrome (Phase 2)
Tobacco Use Disorder (Phase 4)
Toxemia (Phase 2)
Underage Drinking (Phase 2)
Weight Gain (Phase 2)